Guangdong Zhongsheng Pharmaceutical Co., Ltd.

XSEC:002317 Stock Report

Market Cap: CN¥10.3b

Guangdong Zhongsheng Pharmaceutical Management

Management criteria checks 3/4

Guangdong Zhongsheng Pharmaceutical's CEO is Yong Hong Chen, appointed in Jan 2011, has a tenure of 13.92 years. directly owns 1.62% of the company’s shares, worth CN¥166.21M. The average tenure of the management team and the board of directors is 6 years and 5 years respectively.

Key information

Yong Hong Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.9yrs
CEO ownership1.6%
Management average tenure6yrs
Board average tenure5yrs

Recent management updates

Recent updates


CEO

Yong Hong Chen (53 yo)

13.9yrs

Tenure

CN¥498,700

Compensation

Mr. Yong Hong Chen serves as General Manager of Guangdong Huanan Pharmaceutical Group Co., Ltd. and Guangdong Zhongsheng Pharmaceutical Trade Co., Ltd. Mr. Chen serves as Executive Director of Guangdong Zh...


Leadership Team

NamePositionTenureCompensationOwnership
Yong Hong Chen
Chairman & President13.9yrsCN¥498.70k1.62%
CN¥ 166.2m
Yuchong Zhang
Vice Chairman & Senior VP8yrsCN¥311.50k10.95%
CN¥ 1.1b
Chun Hua Long
VP, CFO14.8yrsCN¥372.90k0.43%
CN¥ 43.7m
Xi Ping Zhao
VP & Director2yrsCN¥372.90k0.92%
CN¥ 94.2m
Shuang Liu
Vice President6yrsCN¥547.40kno data
Wei Yang
Board Secretary1.6yrsno datano data
Rikang Luo
Vice Presidentless than a yearno data0.0012%
CN¥ 121.1k

6.0yrs

Average Tenure

49yo

Average Age

Experienced Management: 002317's management team is seasoned and experienced (6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yong Hong Chen
Chairman & President13.9yrsCN¥498.70k1.62%
CN¥ 166.2m
Yuchong Zhang
Vice Chairman & Senior VP8yrsCN¥311.50k10.95%
CN¥ 1.1b
Chun Hua Long
VP, CFO10.9yrsCN¥372.90k0.43%
CN¥ 43.7m
Xi Ping Zhao
VP & Director2yrsCN¥372.90k0.92%
CN¥ 94.2m
Wen Tan
Non-Independent Director5yrsCN¥72.00kno data
Pengan Shan
Non-Independent Director8yrsCN¥72.00kno data
Ruichao Lin
Independent Director5yrsCN¥72.00kno data
Qinggong Wu
Independent Director5yrsCN¥72.00kno data
So Hyun Lee
Supervisor8yrsno datano data
Xiaorong Mou
Independent Director2.6yrsCN¥45.00kno data
Zhenyou Tan
Chairman of the Supervisory Board2yrsno datano data
Hougan Huang
Employee Supervisorless than a yearno datano data

5.0yrs

Average Tenure

53yo

Average Age

Experienced Board: 002317's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 13:06
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhi Xue DiaoAvic Securities Co., Ltd
Shanshan LiChina Merchants Securities Co. Ltd.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)